Besse BMD - Search Results

1

Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort.

Remon J, Auclin E, Zubiri L, Schneider S, Rodriguez-Abreu D, Minatta N, Gautschi O, Aboubakar F, Muñoz-Couselo E, Pierret T, Rothschild SI, Cortiula F, Reynolds KL, Thibault C, Gavralidis A, Blais N, Barlesi F, Planchard D, Besse BMD. Remon J, et al. Among authors: besse bmd. ESMO Open. 2024 May;9(5):103004. doi: 10.1016/j.esmoop.2024.103004. Epub 2024 Apr 22. ESMO Open. 2024. PMID: 38653155 Free PMC article.

2

[Targeting epidermal growth factor receptor in non-small cell lung cancer: current advances and perspectives].

Italiano A, Besse B, Planchard D, Soria JC. Italiano A, et al. Bull Cancer. 2007;94(7 Suppl):F177-88. Bull Cancer. 2007. PMID: 17964994 Review. French.

3

[Angiogenesis targeting in lung cancers].

Planchard D, Besse B. Planchard D, et al. Bull Cancer. 2007;94(7 Suppl):F217-22. Bull Cancer. 2007. PMID: 17964999 Review. French.

4

Mitogen-activated protein kinase activation in lung adenocarcinoma: a comparative study between ever smokers and never smokers.

Mountzios G, Planchard D, Besse B, Validire P, Girard P, Devisme C, Dimopoulos MA, Soria JC, Fouret P. Mountzios G, et al. Clin Cancer Res. 2008 Jul 1;14(13):4096-102. doi: 10.1158/1078-0432.CCR-07-4150. Clin Cancer Res. 2008. PMID: 18593986

5

[Towards customized therapy for non small cell lung cancer].

Planchard D, Besse B. Planchard D, et al. Bull Cancer. 2008 Oct;95(10):951-8. doi: 10.1684/bdc.2008.0719. Bull Cancer. 2008. PMID: 19004725 Free article. French.

6

[Lung cancer in never smoker: Epidemiology, molecular profiles and treatment].

Hadoux J, Besse B, Planchard D. Hadoux J, et al. Presse Med. 2011 Apr;40(4 Pt 1):371-8. doi: 10.1016/j.lpm.2011.02.001. Epub 2011 Mar 21. Presse Med. 2011. PMID: 21420271 Review. French.

7

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.

Besse B, Planchard D, Veillard AS, Taillade L, Khayat D, Ducourtieux M, Pignon JP, Lumbroso J, Lafontaine C, Mathiot C, Soria JC. Besse B, et al. Lung Cancer. 2012 Apr;76(1):78-83. doi: 10.1016/j.lungcan.2011.09.006. Epub 2011 Dec 18. Lung Cancer. 2012. PMID: 22186627 Clinical Trial.

8

Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.

Abedallaa N, Tremblay L, Baey C, Fabre D, Planchard D, Pignon JP, Guigay J, Pechoux CL, Soria JC, de Montpreville VT, Besse B. Abedallaa N, et al. J Thorac Oncol. 2012 Jul;7(7):1179-83. doi: 10.1097/JTO.0b013e3182572ead. J Thorac Oncol. 2012. PMID: 22617247 Free article.

9

Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives.

Mazières J, Peters S, Lepage B, Cortot AB, Barlesi F, Beau-Faller M, Besse B, Blons H, Mansuet-Lupo A, Urban T, Moro-Sibilot D, Dansin E, Chouaid C, Wislez M, Diebold J, Felip E, Rouquette I, Milia JD, Gautschi O. Mazières J, et al. J Clin Oncol. 2013 Jun 1;31(16):1997-2003. doi: 10.1200/JCO.2012.45.6095. Epub 2013 Apr 22. J Clin Oncol. 2013. PMID: 23610105

10

Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trials.

Levy A, Gomez-Roca C, Massard C, Planchard D, Albiges L, Bahleda R, Bourgier C, Deutsch E, Soria JC, Besse B. Levy A, et al. Onkologie. 2013;36(6):357-62. doi: 10.1159/000351257. Epub 2013 May 13. Onkologie. 2013. PMID: 23774150 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page